13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001535610
Total reported value
$110.5M
$110.5M
27 檔
41.1%
During the Q4 2024 filing period, Sabby Management, LLC (CIK: 0001535610) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $110.5M across 27 reported positions.
In Q4 2024, Sabby Management, LLC adopted a defensive or profit-taking posture, trimming 9 positions and completely liquidating 29 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Ishares Tr | Stock-Other | 47.64% | +11.16% | -36.57% | |
| 2 | ✓ | Core Scientific Inc New | Stock-Other | 19.13% | — | — | |
| 3 | EOSE | Eos Energy Enterprises Inc | Stock-Other | 7.51% | — | — | |
| 4 | ✓ | Eos Energy Enterprises Inc | Stock-Other | 4.64% | — | +63.15% | |
| 5 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 3.48% | -16.20% | — | |
| 6 | IWM | Ishares Russell 2000 ETF | ETF-Small Cap | 3.18% | — | — | |
| 7 | VANI | Vivani Medical Inc | Stock-Other | 2.76% | — | -38.37% | |
| 8 | ✓ | Bit Digital Inc | Stock-Other | 2.52% | — | — | |
| 9 | ✓ | Bit Digital Inc | Stock-Other | 1.86% | — | -43.91% | |
| 10 | ✓ | Eos Energy Enterprises Inc | Stock-Other | 1.53% | — | — | |
| 11 | ✓ | Reviva Pharmaceutcls Hldgs Inc | Stock-Other | 1.26% | — | +3975.53% | |
| 12 | ✓ | Checkpoint Therapeutics Inc | Stock-Other | 1.05% | — | +2.44% | |
| 13 | CORZ | Core Scientific Inc | Stock-Tech | 0.60% | — | -30.71% | |
| 14 | CVM1EUR | Cel-sci CORP | Stock-Other | 0.52% | — | — | |
| 15 | ✓ | Volcon Inc | Stock-Other | 0.43% | — | — | |
| 16 | ✓ | Lichen China LTD | Stock-Other | 0.40% | — | — | |
| 17 | ✓ | Universe Pharmaceuticals Inc | Stock-Other | 0.37% | — | — | |
| 18 | ✓ | Spdr S&P 500 Etf Tr Put Option | ETF-Large Cap & Growth | 0.28% | +45.73% | -78.83% | |
| 19 | ✓ | Zevra Therapeutics Inc | Stock-Other | 0.25% | -3.00% | — | |
| 20 | ✓ | Stock-Other | 0.22% | — | — | ||
| 21 | HCWC | Healthy Choice Wellness CORP | Stock-Other | 0.10% | — | -83.82% | |
| 22 | ✓ | Ishares Tr | Stock-Other | 0.09% | +12.02% | NEW | |
| 23 | ✓ | Cn Energy Group Inc | Stock-Other | 0.05% | — | — | |
| 24 | ✓ | Digital Ally Inc | Stock-Other | 0.05% | — | — | |
| 25 | ✓ | Foxo Technologies Inc | Stock-Other | 0.04% | — | — | |
| 26 | SPY | State Street SPDR S&P 500 ETF Trust | ETF-Large Cap & Growth | 0.02% | +13.85% | NEW | |
| 27 | SXTPW | 60 Degrees Pharma Inc-28 | Stock-Other | 0.01% | — | -40.28% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Ishares Tr | +45.8% | -36.57% | Trim |
| 2 | EOSE | Eos Energy Enterprises Inc | +7.5% | NEW | New buy |
| 3 | SPY | Ss Spdr S&p 500 ETF Trust-us | +3.5% | NEW | New buy |
| 4 | IWM | Ishares Russell 2000 ETF | +3.2% | NEW | New buy |
| 5 | ✓ | Bit Digital Inc | +2.5% | NEW | New buy |
| 6 | ✓ | Eos Energy Enterprises Inc | +1.5% | NEW | New buy |
| 7 | ✓ | Reviva Pharmaceutcls Hldgs Inc | +1.2% | +3975.53% | Add |
| 8 | CVM1EUR | Cel-sci CORP | +0.5% | NEW | New buy |
| 9 | ✓ | Volcon Inc | +0.4% | NEW | New buy |
| 10 | ✓ | Lichen China LTD | +0.4% | NEW | New buy |
| 11 | ✓ | Universe Pharmaceuticals Inc | +0.4% | NEW | New buy |
| 12 | ✓ | Eos Energy Enterprises Inc | +0.3% | +63.15% | Add |
| 13 | ✓ | Zevra Therapeutics Inc | +0.3% | NEW | New buy |
| 14 | ✓ | +0.2% | NEW | New buy | |
| 15 | ✓ | Cn Energy Group Inc | +0.1% | NEW | New buy |
| 16 | ✓ | Digital Ally Inc | +0.1% | NEW | New buy |
| 17 | ✓ | Foxo Technologies Inc | 0% | NEW | New buy |
| 18 | ✓ | 0% | EXIT | Sold out | |
| 19 | ✓ | Wearable Devices LTD | 0% | EXIT | Sold out |
| 20 | EFTR | Effector Therapeutics Inc | 0% | EXIT | Sold out |
| 21 | ✓ | Atossa Therapeutics Inc | 0% | EXIT | Sold out |
| 22 | ✓ | Scilex Holding Co | 0% | EXIT | Sold out |
| 23 | SCLXUSD | Scilex Holding Co | 0% | EXIT | Sold out |
| 24 | ✓ | 0% | EXIT | Sold out | |
| 25 | AMPGW | Amplitech Group Inc-cw26 | 0% | EXIT | Sold out |
| 26 | SXTPW | 60 Degrees Pharma Inc-28 | -0.1% | -40.28% | Trim |
| 27 | KPRX | Kiora Pharmaceuticals Inc | -0.1% | EXIT | Sold out |
| 28 | ✓ | Globus Maritime Limited New | -0.1% | EXIT | Sold out |
| 29 | ✓ | Revelation Biosciences Inc | -0.2% | EXIT | Sold out |
| 30 | ✓ | -0.2% | EXIT | Sold out | |
| 31 | ✓ | Bluejay Diagnostics Inc | -0.2% | EXIT | Sold out |
| 32 | VVOS | Vivos Therapeutics Inc | -0.2% | EXIT | Sold out |
| 33 | NRXP | Nrx Pharmaceuticals Inc | -0.3% | EXIT | Sold out |
| 34 | ✓ | Ishares Tr | -0.4% | -48.25% | Trim |
| 35 | SIDU | Sidus Space Inc-cl A | -0.4% | EXIT | Sold out |
| 36 | PHIO | Phio Pharmaceuticals CORP | -0.4% | EXIT | Sold out |
| 37 | ✓ | -0.6% | EXIT | Sold out | |
| 38 | ✓ | Nrx Pharmaceuticals Inc | -0.6% | EXIT | Sold out |
| 39 | ✓ | -0.6% | EXIT | Sold out | |
| 40 | SNES | Senestech Inc | -0.7% | EXIT | Sold out |
| 41 | ATXI | Avenue Therapeutics Inc | -0.7% | EXIT | Sold out |
| 42 | ✓ | Checkpoint Therapeutics Inc | -0.7% | +2.44% | Add |
| 43 | ✓ | -1% | EXIT | Sold out | |
| 44 | SCPX | Scorpius Holdings Inc | -1.1% | EXIT | Sold out |
| 45 | CORZ | Core Scientific Inc | -1.2% | -30.71% | Trim |
| 46 | ✓ | Ensysce Biosciences Inc | -1.3% | EXIT | Sold out |
| 47 | ✓ | -1.7% | EXIT | Sold out | |
| 48 | SPY | State Street SPDR S&P 500 ETF Trust | -1.9% | -97.20% | Trim |
| 49 | CORZ | Core Scientific, Inc. | -2.3% | EXIT | Sold out |
| 50 | CLSNEUR | Imunon Inc | -2.9% | EXIT | Sold out |
According to official SEC Form 13F filings, Sabby Management, LLC reported a total U.S. public equity portfolio value of $110.5M across 27 disclosed positions in Q4 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including ISHARES TR, CORE SCIENTIFIC INC NEW, EOSE) accounted for 41.1% of total reported equity market value during Q4 2024.
Top New Position Initiated
EOSE
市值: $4.1M
Top Position Liquidated / Trimmed
VOLCON INC
前期市值: $805.6K
During Q4 2024, Sabby Management, LLC's top holdings by market value included ISHARES TR (47.6%)、CORE SCIENTIFIC INC NEW (19.1%)、EOSE (7.5%). The largest single position, ISHARES TR, represented 47.6% of total portfolio value.
In Q4 2024, Sabby Management, LLC made 55 total portfolio adjustments, initiating 14 new buys, adding to 3 positions, trimming 9 holdings, and fully liquidating 29 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.